Literature DB >> 10795950

Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives.

H E Jones1, N A Haug, M L Stitzer, D S Svikis.   

Abstract

The aim of this study was to examine the effectiveness of low-magnitude behavioral incentives in improving attendance for abstinence-treated patients and sustaining illicit-drug abstinence for methadone-treated patients. Subjects were randomly assigned to either incentive or control conditions, with target behaviors differing for the two patient groups (attendance for abstinence-treated and abstinence for methadone-treated patients). Controls received no incentives, whereas incentive subjects could earn $5/day in vouchers during the first 7 days of an intensive outpatient treatment. Results showed that $5/day did not significantly improve attendance in abstinence-treated patients or impact drug abstinence in methadone-treated patients. The data suggest that low-magnitude voucher incentives enhanced treatment attendance by methadone-treated subjects. Although modest monetary incentives had some utility in improving attendance in methadone-treated patients, more potent interventions are needed to improve attendance and maintain abstinence in this high-risk population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795950     DOI: 10.1016/s0306-4603(98)00119-1

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  17 in total

1.  A tale of two cities: financing two voucher programs for substance abusers through community donations.

Authors:  Leslie Amass; Jonathan Kamien
Journal:  Exp Clin Psychopharmacol       Date:  2004-05       Impact factor: 3.157

Review 2.  Contingency management interventions for tobacco and other substance use disorders in pregnancy.

Authors:  Dennis J Hand; Jennifer D Ellis; Meagan M Carr; Diane J Abatemarco; David M Ledgerwood
Journal:  Psychol Addict Behav       Date:  2017-06-22

3.  Interdependent group contingency management for cocaine-dependent methadone maintenance patients.

Authors:  Kimberly C Kirby; Marylouise E Kerwin; Carolyn M Carpenedo; Beth J Rosenwasser; Robert S Gardner
Journal:  J Appl Behav Anal       Date:  2008

4.  Effectiveness of Using Incentives to Improve Parolee Admission and Attendance in Community Addiction Treatment.

Authors:  Michael L Prendergast; Elizabeth A Hall; Jason Grossman; Robert Veliz; Liliana Gregorio; Umme S Warda; Kory Van Unen; Chloe Knight
Journal:  Crim Justice Behav       Date:  2015-07-10

5.  Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study.

Authors:  Gerald T Cochran; Valerie Hruschak; Walitta Abdullah; Elizabeth Krans; Antoine B Douaihy; Stephanie Bobby; Rachel Fusco; Ralph Tarter
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

6.  A treatment for substance abusing pregnant women.

Authors:  Kimberly Ann Yonkers; Heather B Howell; Amy E Allen; Samuel A Ball; Michael V Pantalon; Bruce J Rounsaville
Journal:  Arch Womens Ment Health       Date:  2009-04-07       Impact factor: 3.633

7.  External pressure, motivation, and treatment outcome among pregnant substance-using women.

Authors:  Steven J Ondersma; Theresa Winhusen; Daniel F Lewis
Journal:  Drug Alcohol Depend       Date:  2009-11-17       Impact factor: 4.492

8.  Incentives for retention of pregnant substance users: a secondary analysis.

Authors:  Gregory Brigham; Theresa Winhusen; Daniel Lewis; Frankie Kropp
Journal:  J Subst Abuse Treat       Date:  2009-07-03

9.  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Emily C Brigham; Eric C Strain; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Sep-Oct

10.  Suicidality, aggression, and other treatment considerations among pregnant, substance-dependent women with posttraumatic stress disorder.

Authors:  A Meade Eggleston; Patrick S Calhoun; Dace S Svikis; Michelle Tuten; Margaret S Chisolm; Hendree E Jones
Journal:  Compr Psychiatry       Date:  2009-01-16       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.